Success Story: An Indian Research Scientist Working in the Field of Biotechnologies Obtains NIW Approval in just 6 days with the help of NAILG’s Experts

Posted by wegreened on May 1, 2024 in NIW, Technology (Nanotechnology, Nanoscience, Biomaterials, Biomechanics, Biomedical Engineering, Bioinformatics, Bioengineering, Biomedical Science, Biotechnologies)

Client’s Testimonial:

“Awesome news, thanks a lot for helping with the filing throughout the process. It was of much help that I was assisted at each step regarding filing my case.”

On May 1^st, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Biotechnologies (Approval Notice).

General Field: Biotechnologies

Position at the Time of Case Filing: Research Scientist

Country of Origin: India

State of Residence at the Time of Filing: Texas

Approval Notice Date: May 1^st, 2023

Processing Time: 6 days (Premium Processing Requested)

Case Summary:

A client from India with a Ph.D. in life sciences approached us to help him file the I-140 NIW (National Interest Waiver) petition; we, therefore, employed our team of experts to build a convincing case for him. We included details from his professional and academic career in his petition packet to support his claim to the NIW category.

We showcased that along with his academic qualification:

He was also actively engaged in the field of biotechnologies as a Research Scientist.

And that his proposed endeavor of defining molecular mechanisms mediating chromatin regulation in order to discover novel nodes for the discovery of drugs that treat rhabdomyosarcomas and other cancers has both substantial merit and national importance.

Furthermore, due to its evident national importance, the client's research has been supported with funding from the National Institutes of Health (NIH), the Wellcome Trust and the Cancer Prevention & Research Institute of Texas. These funding is reserved solely for research directed at advancing the national interest, including the promotion of health and longevity in the American population

On the other hand, we highlighted that his academic performance has been responsible for several publications, and citations:

His research has resulted in 8 peer-reviewed journal articles (2 of them first-authored).
His publications have been cited 341 times according to Google Scholar.
He has completed at least 120 reviews to date for at least 4 Journals.

Not only this but the recommendations had an excellent review of his work, one (out of four) of which are quoted below:

“[Client’s] research in the field of biotechnologies is primarily concentrated on the study of muscle cells as they relate to cancer and disease functions. This is a valuable area of research for the United States, considering the high incidence of these conditions in the American population…[Client’s] research understanding the mechanisms of this cancer is valuable for developing more effective, less invasive treatment approaches. Therefore, it is evident that [client] is an asset to the United States and his peers in biotechnologies.”

Based on this multifactorial assessment, it is clear that the client’s education, experience, expertise, documented record of success, influence in his field, and plan have altogether well-positioned him in his field of expertise.

We are thus very proud that our client got his NIW approval in just 6 days (thanks to premium processing) and has even retained us for his EB1A case which is filed. It has been an amazing journey with him. We wish him the very best in his future endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%